Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Gapping up/down: TZOO +12%, CLF +10%, CVS +2% and TOT +1% after earnings, RMBS +3% after upgrade; TWTR -9%, MC -3%, FISV -3% and KO -2% after earnings<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>SKYS</strong> +65.8%, (thinly traded), <strong>OSUR</strong> +23.4%, <strong>AVNW</strong> +15.9%, (thinly traded), <strong>TZOO</strong> +11.6%, <strong>PAYC</strong> +11%, <strong>ZEN</strong> +10.1%, <strong>MPAA</strong> +9.8%, <strong>CLF</strong> +9.8%, <strong>PCMI</strong> +9.5%</li><li><strong>IMPV</strong> +9.3%, (also agrees to sell its Skyfence technology and service to Forcepoint, financial details not disclosed; acquires the assets of Camouflage Software)</li><li><strong>WSTL</strong> +8.4%, <strong>FLT</strong> +7.8%, <strong>PRLB</strong> +6.5%, <strong>SCSS</strong> +6.2%, <strong>MDSO</strong> +6.1%, <strong>LLNW</strong> +5.4%, <strong>CXW</strong> +5.2%, <strong>LIVE</strong> +4.4%, <strong>ARRY</strong> +3.5%, <strong>ALNY</strong> +3.4%, <strong>RLGT</strong> +3.4%</li><li><strong>VIA</strong> +3%, <strong>CMP</strong> +2.9%, <strong>FONR</strong> +2.7%, <strong>AOSL</strong> +2.5%, <strong>GPRE</strong> +2.2%, <strong>CVS</strong> +2.2%, <strong>MFC</strong> +2%, <strong>EFX</strong> +1.9%, <strong>TU</strong> +1.9%, <strong>CETX</strong> +1.9%, <strong>FORM</strong> +1.6%, <strong>CMI</strong> +1.6%</li><li><strong>PTN</strong> +1.4%, <strong>WWE</strong> +1.4%, <strong>BGCP</strong> +1.3%, <strong>ROP</strong> +1.2%, <strong>RAI</strong> +1.1%, <strong>PSEC</strong> +1%, <strong>TOT</strong> +1%, <strong>RMR</strong> +0.9%, <strong>OHI</strong> +0.8%, <strong>CRAY</strong> +0.8%, <strong>AFG</strong> +0.7%, <strong>YUM</strong> +0.6%, <strong>PRU</strong> +0.5%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>JAGX</strong> +69% (Jaguar Animal Health to merge with Napo Pharmaceuticals)</li><li><strong>NOK</strong> +1.4% (to acquire Comptel for EUR 347 mln)</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>ETRM</strong> +17.8% (publication of three-year data from the Company's VBLOC DM2 Study of vBloc Neurometabolic Therapy)</li><li><strong>AQMS</strong> +16.1% (announces that Johnson Controls (JCI) finalized an agreement covering North America, China and Europe for its technology)</li><li><strong>RELV</strong> +14.7% (thinly traded; announced that CardioSentials heart health supplement has earned a U.S. patent)</li><li><strong>ACOR</strong> +12.3% (announces 'positive' Phase 3 data of CVT-301 'showing a statistically significant improvement in motor function in people with Parkinson's disease experiencing OFF periods)</li><li><strong>VKTX</strong> +11.7% (announces 'positive' initial results from a proof-of-concept study of VK2809)</li><li><strong>PPHM</strong> +9.9% (announces the publication of positive proof-of-concept data for a novel exosome-based cancer detection platform)</li><li><strong>BANC</strong> +5.6% (Banc of California appoints Richard Lashley, co-founder of 6.9% holder PL Capital Advisors, to the Board and approves certain enhancements to corporate governance policies)</li><li><strong>URRE</strong> +3.8% (announces its Special meeting not convened, nor adjourned to later date; RCF debt to be repaid from treasury)</li><li><strong>STB</strong> +3.2% ( awarded new record $187 million contract )</li><li><strong>SNY</strong> +2.3% (Regeneron Pharma confirms appeals court grants stay of permanent injunction for Praluent (alirocumab) during appeals process)</li><li><strong>TSLA</strong> +2.1% (Reuters details that Tesla (TSLA) plans to pause factory production in California to prepare for Model 3)</li><li><strong>XGTI</strong> +2.1% (prices offering of 1.75 mln shares of common stocks and warrants of up to 1.3 mln shares at $2.00 per share)</li><li><strong>ETP</strong> +1.7% (received US Army Corps of Engineers easement to construct N Dakota pipeline (as expected — see Feb 7 comments); Dakota Access has now received all federal authorizations necessary to proceed)</li><li><strong>BP</strong> +1.1% (in sympathy with TOT earnings)</li><li><strong>RDS.A</strong> +1.1% (in sympathy with TOT earnings)</li><li><strong>DECK</strong> +0.9% (following late move higher on Marcato active stake disclosure)</li><li><strong>BA</strong> +0.8% (confirms that Singapore Airlines has commited to purchase 20 777-9s and 19 787-10 Dreamliners)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>RMBS</strong> +2.8% (upgraded to Overweight from Neutral at JP Morgan)</li><li><strong>FNV</strong> +0.7% (upgraded to Neutral from Sell at Goldman)</li><li><strong>ALV</strong> +0.6% (upgraded to Overweight from Sector Weight at KeyBanc Capital Mkts)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>SNCR</strong> -15.9%, <strong>LPSN</strong> -15.2%, <strong>FSC</strong> -13.4%, <strong>MTRX</strong> -10.6%, <strong>MB</strong> -10.5%, <strong>QLYS</strong> -9.1%, <strong>TWTR</strong> -8.9%, <strong>IRBT</strong> -8.8%, <strong>BGC</strong> -8%, <strong>VSTO</strong> -7.6%, <strong>SON</strong> -7.5%, <strong>OII</strong> -7%</li><li><strong>MXL</strong> -6.9%, <strong>LQDT</strong> -6.8%, <strong>GLUU</strong> -6%, <strong>STRL</strong> -5.8%, (sees Q4 net loss of $5.5-6.5 mln and revs of $165-170 mln vs. $157.25 mln two analyst estimate; says results are 'very disappointing')</li><li><strong>ECHO</strong> -5.3%, <strong>COTY</strong> -5.2%, <strong>ENSG</strong> -5%, <strong>TYL</strong> -4.8%, <strong>CDE</strong> -4.2%, <strong>TBI</strong> -3.6%, <strong>KS</strong> -3.4%, <strong>ENTA</strong> -3.3%, <strong>UHAL</strong> -3%, <strong>MC</strong> -3%, <strong>SNN</strong> -2.9%, <strong>FSFR</strong> -2.8%, <strong>FISV</strong> -2.6%</li><li><strong>PPC</strong> -2.1%, <strong>KO</strong> -2.1%, <strong>GLAD</strong> -1.7%, <strong>AGTC</strong> -1.5%, <strong>MAS</strong> -1.5%, <strong>CTL</strong> -1.4%, <strong>PDS</strong> -1.3%, <strong>DTE</strong> -1.2%, <strong>REGN</strong> -1.2%, <strong>JE</strong> -1%, <strong>CX</strong> -0.6%, <strong>SEE</strong> -0.5%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>SRRA</strong> -9.1% (to offer shares of its common stock in an underwritten public offering; size not disclosed)</li><li><strong>CREE</strong> -5.5% (CFIUS informed Infineon and Cree that the Wolfspeed transaction poses a risk to the national security of the United States)</li><li><strong>AMGN</strong> -1.4%/ <strong>REGN</strong> -1.2% (Regeneron Pharma confirms appeals court grants stay of permanent injunction for Praluent (alirocumab) during appeals process)</li><li><strong>TM</strong> -1.2% (traded ~2% lower in Japan overnight)</li><li><strong>HLI</strong> -1.1% (prices offering of 8 mln shares of common stock by co and selling shareholders at $29.25 per share)</li><li><strong>FSLR</strong> -1% (awarded module supply contract for the 140 megawatt DC Sun Metals Solar Farm in North Queensland)</li><li><strong>PYPL</strong> -0.9% (discloses that it has received subpoenas from the DOJ seeking the production of certain information related to the company's historical anti-money laundering program)</li><li><strong>KR</strong> -0.9% (WFM sympathy)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>SLW</strong> -1% (downgraded to Neutral from Buy at Goldman)</li><li><strong>FCX</strong> -1% (resumed with a Neutral at JP Morgan)</li></ul></td> </tr></table>"